Literature DB >> 17001857

[E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].

G Sengöz1, K Kart Yaşar, S Bati Kutlu, Y Bilgin Durdu, R Ozdemir, O Nazlican.   

Abstract

Although Brucella species are susceptible to many antimicrobial agents in vitro, the susceptibility tests for these bacteria are not well standardized and the break point values are not described yet clearly. The aim of this study was to investigate the minimum inhibitory concentration (MIC) values of 43 Brucella strains isolated from blood cultures by E-test. Streptomycin and rifampicin E-tests were performed for all of the strains, however, tetracycline and ciprofloxacin were tested for only 27 and 17 strains, respectively. The MIC interval for streptomycin was 0.025-1 mg/L, for rifampicin 0.19-1.5 mg/L, for tetracycline <0.016-0.032 mg/L, and for ciprofloxacin 0.094-0.64 mg/L. One strain was found intermediately susceptible to rifampicin. In may be concluded that development of resistance is not eligible against antibiotics which are currently used for brucellosis therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001857

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  1 in total

1.  Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis.

Authors:  Rohaidah Hashim; Norazah Ahmad; Jama'ayah Mohamed Zahidi; B Y Tay; Azura Mohd Noor; Sakina Zainal; Hazwani Hamzah; S H Hamzah; T S Chow; P S Wong; K N Leong
Journal:  Int J Microbiol       Date:  2014-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.